Q. What does Puma Biotechnology do?
A. Puma is a development-stage biopharmaceutical company that acquires and
develops innovative products for the treatment of various forms of cancer. Puma
focuses on in-licensing drug candidates that are undergoing or have already
completed initial clinical testing for the treatment of cancer and then seeks to further
develop those drug candidates for commercial use.
 |
Q. When was Puma founded and where was it incorporated?
A. Puma was founded in September 2010 as a private company and incorporated in
Delaware.
|
Q. When did Puma become a public company?
A. On October 4, 2011, Puma completed a reverse merger with Innovative Acquisitions
Corp., a publicly reporting "shell" company with no specific business plan or
purpose. As a result of the merger, Puma became a wholly owned subsidiary
of Innovative Acquisitions. The merged company changed its name to Puma
Biotechnology and adopted Puma’s business plan. The company’s common stock
began trading on April 20, 2012.
|
Q. On which exchange is Puma’s stock traded and what is the stock symbol?
A. Puma Biotechnology common stock began trading on the New York Stock Exchange on October 19, 2012 under the trading symbol "PBYI." Previously, PBYI was quoted on the OTC Bulletin Board and OTCQB Market.
|
Q. How many shares of Puma Biotechnology common stock are outstanding?
A. As of October 24, 2012, there were 28,665,000 shares of Puma Biotechnology common stock issued and outstanding.
|
Q. What is Puma’s CUSIP number?
A. The CUSIP number for Puma Biotechnology common stock is 74587V107.
|
Q. Does Puma pay dividends on its common stock?
A. No.
|
Q. Does Puma offer a Direct Stock Purchase Plan?
A. No.
|
Q. Who serves as Puma’s stock transfer agent?
A. Wells Fargo Shareowner Services ℠.
|
Q. If I’ve lost my stock certificate or have a change of address, whom should I
contact?
A. Wells Fargo Shareowner Services ℠
P.O. Box 64854
St Paul, MN 55164
Phone: (1) 800-468-9716
Website: www.shareowneronline.com
|
Q. Who is Puma’s independent registered public accounting firm?
A. PKF Certified Public Accountants, a Professional Corporation
2020 Camino del Rio North, Suite 500
San Diego, CA 92108
|
Q. When does Puma’s fiscal year end?
A. December 31.
|
Q. When and where was Puma’s annual meeting of stockholders held?
A. The annual meeting of stockholders was held on June 13, 2012, at the Luxe Sunset
Boulevard Hotel in Los Angeles.
|
Q. Where are Puma’s headquarters located?
A. Puma’s headquarters are located at 10880 Wilshire Blvd., Suite 2150, Los Angeles,
CA 90024.
|
Q. How can I get copies of Puma’s financial statements or other regulatory filings?
A. Puma’s financial statements and other reports filed with the SEC are available on
the SEC Filings page of our website at http://ir.pumabiotechnology.com/sec.cfm.
|
Q. If I have questions regarding the company, whom should I contact?
A. Please contact Mariann Ohanesian, Senior Director, Investor Relations:
Phone: (1) 424-248-6500, Ext. 2011
Email: ir@pumabiotechnology.com
|
